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Abstract
Introduction: Marijuana or “bong” lung has been recently described. Subjects typically develop large peripheral
paraseptal lung bullae and are predisposed to spontaneous pneumothoraces. The underlying mechanism for bullae
formation is uncertain, but probably relates to direct lung toxicity and repeated barotrauma as the smoker
performs frequent valsalva manoeuvres in an attempt to derive a greater drug effect.
Case presentation: We describe a case of probable “bong lung” occurring in a 23-year-old Caucasian man with
cystic fibrosis who had a history of recurrent pneumothoraces and unusual findings on sputum cytology.
Conclusion: Our case highlights the importance of questioning young adult cystic fibrosis patients about illicit
drug use and the utility of sputum cytology and computed tomography scanning when patients present with
pneumothoraces and deteriorations in clinical status.
Introduction
Marijuana smoking has recently been identified as a risk
factor for bullous lung disease and the occurrence of
recurrent pneumothoraces [1,2]. Upper lobe lung deposi-
tion of hot particulate matter following inhalation stimu-
lates an inflammatory response that is characterised by the
accumulation of carbon-laden alveolar macrophages (AM)
and polymorphonuclear cells (PMNs) in the airway lumen
and lung parenchyma [3]. Marijuana suppresses the ability
of AM to phagocytose pathogens with an increased risk of
airway infection and lung abscesses [4,5]. There are also
suggestions that marijuana smoking increases the risk of
lung cancer, although this is as yet not definitely estab-
lished [6,7].
We describe the case of a 23-year-old Caucasian man
with cystic fibrosis (CF) with recurrent pneumothoraces,
which were most probably due to “bong lung” and the
presence of unusual findings on sputum cytology.
Case Presentation
A 23-year-old Caucasian man with CF was admitted with
a one-week history of pleuritic chest pain, increased cough
and sputum purulence, accompanied by some minor hae-
moptysis. Lung function had deteriorated; FEV1 of 2.01L
(42% predicted) compared to 2.76L (57% predicted) when
well. On examination, he was clubbed and malnourished
(body mass index: 18), but not cyanosed. Auscultation of
his chest revealed widespread inspiratory crackles over
both upper lobes. A diagnosis of an infective exacerbation
of his bronchiectasis was made. He was continued on
intravenous ceftazidime and tobramycin, regular phy-
siotherapy and nutritional supplementation.
Past medical history consisted of pancreatic insuffi-
ciency and chronic airway sepsis related to Pseudomonas
aeruginosa infection. Diagnosis had been made at birth
and he possessed the ΔF508/1898 + G ® CF gene muta-
tion. He was known to have established osteoporosis and
significant gastro-oesophageal reflux. Over the preceding
two years, he had been admitted to a hospital on 12 occa-
sions with acute exacerbations of his CF lung disease and
during this time period, his forced expiratory volume in
one second L (FEV1) had deteriorated from 3.17 L (74%
predicted) to 2.76L (57% predicted). He also had a past
history of recurrent left-sided pneumothoraces.
During the admission, he developed spiking fevers and
complained of worsening pleuritic pain. A Computed
Tomography (CT) pulmonary angiogram was performed
to look for pulmonary emboli. The CT scan showed no
emboli, but demonstrated large bilateral upper lobe lung
bullae, more prominent on the right side with characteris-
tic bronchiectatic changes elsewhere (Figure 1). Sputum
microscopy revealed the expected predominance of
PMNs, but also droplets of oily brown material embedded
in mucus. PMNs were observed containing vacuoles full of
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droplets could be seen surrounded by palisades of PMNs
(Figure 2). On closer questioning, the patient admitted to
several years of marijuana smoking through a bong. He
denied use of tobacco. A provisional diagnosis of “bong
lung” complicating severe CF bronchiectasis was made.
The patient made a slow recovery over three weeks and
received counselling about his marijuana use. He was dis-
charged with an FEV1 of 2.33L (48% predicted).
Discussion
Marijuana lung has been described in habitual smokers,
but not previously in the setting of CF. Our patient pre-
sented with frequent exacerbations on the background
of recurrent spontaneous pneumothoraces and a rapid
deterioration in lung function. He was found to have
large apical bullae on high-resolution computerized
tomography (HRCT) scanning, similar to those typically
observed in marijuana smokers. To the best of our
knowledge, this is the first reported case of bong lung in
CF, but the prevalence of marijuana use in CF has been
reported to be as high as 20% suggesting this may be a
potentially under-diagnosed condition [8]. Bong lung is
worth considering in CF adults, especially as pneu-
mothorax is such a relatively common complication of
the disease with three quarters of cases occurring in
patients aged over 18 years old [9].
Our case was particularly notable for the novel appear-
ances on sputum microscopy of palisades of PMNs sur-
rounding and trying to engulf/phagocytose droplets of
marijuana. There have been no previous reports of airway
PMNs containing unusual inclusion bodies in marijuana
smokers, but enhanced PMN recruitment and activation
in CF related to marijuana inhalation may exacerbate the
already over-exuberant innate immune response and pro-
mote further lung injury.
Conclusion
Our case highlights the importance of considering drug
abuse/marijuana use in CF patients, particularly in the
context of atypical paraseptal bullae, recurrent pneu-
mothoraces, accelerated decline in lung function and
repeated admissions with increasing airway sepsis. Con-
sideration should be given to sputum cytology and CT
scanning when CF patients develop an unexplained
deterioration in respiratory status.
Consent
Written informed consent was obtained from the patient
for publication of this case report and any accompany-
ing images. A copy of the written consent is available
for review by the Editor-in-Chief of this journal.
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Figure 1 High resolution CT scan of the patient’s lungs
demonstrating apical bullae. Note the prominent bronchial
arteries (arrow).
Figure 2 Sputum cytology using Giemsa stain (x100
magnification and oil immersion lens). Note the brown oily
material (arrows) and surrounding PMNs.
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